232 related articles for article (PubMed ID: 32116234)
1. Identification of hub genes and pathways in cholangiocarcinoma by coexpression analysis.
Kong J; Shen S; Zhang Z; Wang W
Cancer Biomark; 2020; 27(4):505-517. PubMed ID: 32116234
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatics Analysis Identifies the Estrogen Receptor 1 (ESR1) Gene and hsa-miR-26a-5p as Potential Prognostic Biomarkers in Patients with Intrahepatic Cholangiocarcinoma.
Qin X; Song Y
Med Sci Monit; 2020 May; 26():e921815. PubMed ID: 32435051
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional landscape of cholangiocarcinoma revealed by weighted gene coexpression network analysis.
Long J; Huang S; Bai Y; Mao J; Wang A; Lin Y; Yang X; Wang D; Lin J; Bian J; Yang X; Sang X; Wang X; Zhao H
Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33051665
[TBL] [Abstract][Full Text] [Related]
4. Cholangiocarcinoma‑associated genes identified by integrative analysis of gene expression data.
Zhong W; Dai L; Liu J; Zhou S
Mol Med Rep; 2018 Apr; 17(4):5744-5753. PubMed ID: 29436659
[TBL] [Abstract][Full Text] [Related]
5. Transcriptomic analysis and identification of prognostic biomarkers in cholangiocarcinoma.
Li H; Long J; Xie F; Kang K; Shi Y; Xu W; Wu X; Lin J; Xu H; Du S; Xu Y; Zhao H; Zheng Y; Gu J
Oncol Rep; 2019 Nov; 42(5):1833-1842. PubMed ID: 31545466
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive circular RNA expression profiling constructs a ceRNA network and identifies hsa_circ_0000673 as a novel oncogene in distal cholangiocarcinoma.
Zhao X; Zhang X; Zhang Z; Liu Z; Zhu J; Lyu S; Li L; Lang R; He Q
Aging (Albany NY); 2020 Nov; 12(22):23251-23274. PubMed ID: 33221765
[TBL] [Abstract][Full Text] [Related]
7. Screening of potential biomarkers for cholangiocarcinoma by integrated analysis of microarray data sets.
Huang QX; Cui JY; Ma H; Jia XM; Huang FL; Jiang LX
Cancer Gene Ther; 2016; 23(2-3):48-53. PubMed ID: 26679756
[TBL] [Abstract][Full Text] [Related]
8. Identification of co‑expression modules and hub genes of retinoblastoma via co‑expression analysis and protein‑protein interaction networks.
Mao Y; Nie Q; Yang Y; Mao G
Mol Med Rep; 2020 Aug; 22(2):1155-1168. PubMed ID: 32468072
[TBL] [Abstract][Full Text] [Related]
9. Five Core Genes Related to the Progression and Prognosis of Hepatocellular Carcinoma Identified by Analysis of a Coexpression Network.
Kong J; Wang T; Zhang Z; Yang X; Shen S; Wang W
DNA Cell Biol; 2019 Dec; 38(12):1564-1576. PubMed ID: 31633379
[TBL] [Abstract][Full Text] [Related]
10. Weighted gene coexpression network analysis reveals hub genes involved in cholangiocarcinoma progression and prognosis.
Tian A; Pu K; Li B; Li M; Liu X; Gao L; Mao X
Hepatol Res; 2019 Oct; 49(10):1195-1206. PubMed ID: 31177590
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel mutation gene signature HAMP for cholangiocarcinoma through comprehensive TCGA and GEO data mining.
Wang Z; Du Y
Int Immunopharmacol; 2021 Oct; 99():108039. PubMed ID: 34426102
[TBL] [Abstract][Full Text] [Related]
12. Identification and Validation of Novel Biomarkers and Potential Targeted Drugs in Cholangiocarcinoma: Bioinformatics, Virtual Screening, and Biological Evaluation.
Wang J; Zhu W; Tu J; Zheng Y
J Microbiol Biotechnol; 2022 Oct; 32(10):1262-1274. PubMed ID: 36224755
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive transcriptomic landscape of cholangiocarcinoma based on bioinformatics analysis from large cohort of patients.
Li H; Qu L; Zhang H; Liu J; Zhang X
Sci Rep; 2021 Jul; 11(1):13713. PubMed ID: 34211100
[TBL] [Abstract][Full Text] [Related]
14. Identification of transcription factors (TFs) and targets involved in the cholangiocarcinoma (CCA) by integrated analysis.
Yang L; Feng S; Yang Y
Cancer Gene Ther; 2016 Dec; 23(12):439-445. PubMed ID: 27857060
[TBL] [Abstract][Full Text] [Related]
15. Fifteen hub genes associated with progression and prognosis of clear cell renal cell carcinoma identified by coexpression analysis.
Wang Y; Chen L; Wang G; Cheng S; Qian K; Liu X; Wu CL; Xiao Y; Wang X
J Cell Physiol; 2019 Jul; 234(7):10225-10237. PubMed ID: 30417363
[TBL] [Abstract][Full Text] [Related]
16. A novel five-lncRNA signature panel improves high-risk survival prediction in patients with cholangiocarcinoma.
Xie X; Wang Y; Zhang S; Li J; Yu Z; Ding X; Ye L; Gong P; Zhu Q; Li J; Chen Z; Yao X; Du Z; Zeng Q; Chen H; Yang Z; Chen G
Aging (Albany NY); 2021 Jan; 13(2):2959-2981. PubMed ID: 33472169
[TBL] [Abstract][Full Text] [Related]
17. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
18. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
[TBL] [Abstract][Full Text] [Related]
19. Identification of vital modules and genes associated with heart failure based on weighted gene coexpression network analysis.
Bian W; Wang Z; Li X; Jiang XX; Zhang H; Liu Z; Zhang DM
ESC Heart Fail; 2022 Apr; 9(2):1370-1379. PubMed ID: 35128826
[TBL] [Abstract][Full Text] [Related]
20. Opposing Roles of FoxA1 and FoxA3 in Intrahepatic Cholangiocarcinoma Progression.
Thanan R; Kaewlert W; Sakonsinsiri C; Chaiprasert T; Armartmuntree N; Muengsaen D; Techasen A; Klanrit P; Lert-Itthiporn W; Pinlaor S; Pairojkul C
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32151057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
